Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial
Michael Bonelli, Helga Radner, Andreas Kerschbaumer, Daniel Mrak, Martina Durechova, Jutta Stieger, Rusmir Husic, Péter Mandl, Josef S Smolen, Christian Dejaco, Daniel Aletaha
Topics & Concepts
MedicinePolymyalgia rheumaticaTocilizumabPlaceboClinical endpointAdverse effectPrednisoloneInternal medicinePrednisoneGlucocorticoidGiant cell arteritisSurgeryGastroenterologyRandomized controlled trialRheumatoid arthritisDiseaseAlternative medicineVasculitisPathologyVasculitis and related conditionsCoagulation, Bradykinin, Polyphosphates, and AngioedemaSystemic Sclerosis and Related Diseases